DILLON & ASSOCIATES INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
DILLON & ASSOCIATES INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$604
-6.9%
5,925
-7.8%
0.12%
-2.5%
Q2 2023$649
+8.5%
6,424
-1.2%
0.12%0.0%
Q1 2023$598
-21.5%
6,504
-22.3%
0.12%
-27.9%
Q4 2022$762
-99.9%
8,369
-0.9%
0.16%
+10.7%
Q3 2022$642,000
-10.6%
8,4490.0%0.15%
-8.0%
Q2 2022$718,000
-3.5%
8,4490.0%0.16%
+14.9%
Q1 2022$744,000
+1.2%
8,4490.0%0.14%
+10.2%
Q4 2021$735,000
+6.1%
8,4490.0%0.13%
-3.8%
Q3 2021$693,000
-9.9%
8,4490.0%0.13%
-11.9%
Q2 2021$769,000
+7.1%
8,4490.0%0.15%
-1.3%
Q1 2021$718,000
-10.1%
8,449
-0.6%
0.15%
-11.6%
Q4 2020$799,000
+5.7%
8,499
-2.2%
0.17%
-4.9%
Q3 2020$756,0000.0%8,6890.0%0.18%
-11.2%
Q2 2020$756,000
+6.2%
8,6890.0%0.20%
-14.6%
Q1 2020$712,000
-16.1%
8,689
-2.8%
0.24%
+0.8%
Q4 2019$849,000
+11.6%
8,939
+2.2%
0.24%
+2.6%
Q3 2019$761,000
-4.5%
8,749
-0.1%
0.23%
-5.7%
Q2 2019$797,000
-5.0%
8,762
+0.3%
0.25%
-9.9%
Q1 2019$839,000
+7.4%
8,737
-3.9%
0.27%
-8.1%
Q4 2018$781,0000.0%9,0870.0%0.30%
+14.7%
Q3 2018$781,000
+12.7%
9,087
-0.3%
0.26%
+1.2%
Q2 2018$693,000
-18.2%
9,112
-12.9%
0.26%
-21.7%
Q1 2018$847,000
-5.9%
10,462
-2.3%
0.33%
-3.5%
Q4 2017$900,000
-2.3%
10,7120.0%0.34%
-6.6%
Q3 2017$921,000
+3.4%
10,712
-0.2%
0.36%
-1.1%
Q2 2017$891,000
+7.6%
10,737
-4.0%
0.37%
+4.3%
Q1 2017$828,000
+0.6%
11,190
-0.7%
0.35%
-5.9%
Q4 2016$823,000
-16.7%
11,270
-9.9%
0.37%
-18.0%
Q3 2016$988,000
-19.6%
12,512
-15.5%
0.46%
-19.1%
Q2 2016$1,229,000
-8.8%
14,812
-20.9%
0.56%
-9.8%
Q1 2016$1,348,000
-20.1%
18,717
-4.6%
0.62%
-23.4%
Q4 2015$1,688,000
-14.6%
19,627
-8.6%
0.82%
-17.5%
Q3 2015$1,976,000
-6.5%
21,475
-0.4%
0.99%
-3.9%
Q2 2015$2,113,000
-0.5%
21,560
+0.5%
1.03%
+1.0%
Q1 2015$2,124,000
+8.6%
21,456
+2.0%
1.02%
+7.3%
Q4 2014$1,956,000
+0.6%
21,031
+1.6%
0.95%
-4.2%
Q3 2014$1,945,000
+5.2%
20,693
+1.9%
0.99%
+4.8%
Q2 2014$1,848,000
+5.8%
20,314
-1.2%
0.95%
+1.4%
Q1 2014$1,747,000
+6.8%
20,555
+0.5%
0.93%
+5.8%
Q4 2013$1,636,000
+0.6%
20,449
-0.7%
0.88%
-2.9%
Q3 2013$1,627,000
+9.3%
20,599
-1.7%
0.91%
-4.6%
Q2 2013$1,488,00020,9560.95%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders